Ivana Sestak Selected Research

Ivana Sestak Research Topics

Disease

58	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2006
20	Neoplasms (Cancer) 01/2022 - 02/2007
6	Noninfiltrating Intraductal Carcinoma (DCIS) 11/2020 - 01/2011
4	Endometrial Neoplasms (Endometrial Cancer) 11/2016 - 12/2010
3	Venous Thrombosis (Deep-Vein Thrombosis) 02/2016 - 02/2007
2	Melanoma (Melanoma, Malignant) 11/2020 - 12/2010
2	Carpal Tunnel Syndrome 01/2016 - 10/2009
2	Arthralgia (Joint Pain) 12/2014 - 09/2008
2	Pulmonary Embolism 06/2012 - 02/2007
1	Chronic Disease (Chronic Diseases) 06/2021
1	Skin Neoplasms (Skin Cancer) 11/2020
1	Metabolic Bone Diseases (Osteopenia) 01/2019
1	Nausea 10/2017
1	Headache (Headaches) 10/2017
1	Vomiting 10/2017
1	Genetic Risk Score 03/2017
1	Spasm (Spasms) 02/2016
1	Stroke (Strokes) 02/2016
1	Hyperplasia 11/2015
1	Breast Diseases (Breast Disease) 11/2015
1	Cysts 11/2015
1	Carcinogenesis 06/2015
1	Colorectal Neoplasms (Colorectal Cancer) 03/2015
1	Disease Progression 01/2014
1	West Nile Fever 09/2013
1	Weight Gain 07/2012
1	Venous Thromboembolism 06/2012
1	Thromboembolism 06/2012
1	Lung Neoplasms (Lung Cancer) 12/2010
1	Ovarian Neoplasms (Ovarian Cancer) 12/2010
1	Overweight 07/2010
1	Arthritis (Polyarthritis) 09/2008
1	Obesity 09/2008

Drug/Important Bio-Agent (IBA)

34	Tamoxifen FDA LinkGeneric 01/2022 - 08/2006
25	Anastrozole (Arimidex)FDA LinkGeneric 01/2022 - 09/2008
12	Aromatase InhibitorsIBA 11/2020 - 09/2008
12	Hormones (Hormone)IBA 01/2020 - 09/2008
11	Estrogen ReceptorsIBA 01/2021 - 02/2007
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2013
4	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 10/2021 - 10/2013
4	Selective Estrogen Receptor Modulators (SERM)IBA 01/2016 - 12/2012
4	Raloxifene Hydrochloride (Evista)FDA Link 01/2016 - 12/2012
4	Estrogens (Estrogen)FDA Link 06/2015 - 10/2009
2	RNA (Ribonucleic Acid)IBA 02/2021 - 03/2012
2	Risedronic Acid (Actonel)FDA LinkGeneric 01/2019 - 12/2014
2	Formaldehyde (Formol)FDA Link 08/2015 - 03/2012
2	Progesterone Receptors (Progesterone Receptor)IBA 06/2015 - 03/2012
2	Proteins (Proteins, Gene)FDA Link 06/2015 - 03/2012
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Biological ProductsIBA 01/2022
1	sperm releasing substanceIBA 01/2022
1	AdipokinesIBA 06/2021
1	ImmunosorbentsIBA 06/2021
1	EnzymesIBA 06/2021
1	AdiponectinIBA 06/2021
1	LeptinIBA 06/2021
1	Hematoxylin (Haematoxylon)IBA 01/2018
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2018
1	human ERBB2 proteinIBA 11/2016
1	ParaffinIBA 08/2015
1	Phenobarbital (Luminal)FDA Link 08/2015
1	mahuang-tangIBA 06/2015
1	Protein Isoforms (Isoforms)IBA 06/2015
1	Pharmaceutical PreparationsIBA 01/2015
1	CarcinogensIBA 01/2014
1	IntegrinsIBA 01/2014
1	LasofoxifeneIBA 01/2014
1	exemestane (Aromasin)FDA Link 01/2014
1	LY 353381 (LY353381)IBA 01/2014
1	Indicators and Reagents (Reagents)IBA 09/2013
1	Messenger RNA (mRNA)IBA 08/2013
1	antineoplaston A10 (A 10)IBA 05/2013
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 03/2012
1	4-hydroxy-N-desmethyltamoxifenIBA 03/2012
1	Progesterone FDA LinkGeneric 07/2010

Therapy/Procedure

29	Therapeutics 01/2022 - 10/2009
4	Drug Therapy (Chemotherapy) 07/2019 - 09/2008
4	Adjuvant Chemotherapy 07/2019 - 10/2016
2	Aftercare (After-Treatment) 11/2020 - 01/2015
2	Radiotherapy 11/2016 - 01/2011
1	Contraindications 02/2016
1	Chemoprevention 06/2012